Sponsors

And now for something completely different… views from the industry

Recently, Mark Reed canvassed many of his colleagues for their views on how the industry is perceived generally, and what they believe the future holds for the commercial diagnostics sector.

Having been invited to make a contribution to this issue, it is always a pleasure to do so. As there are so many subject matters worthy of an article, the question was what to concentrate on, COVID-19 again? Given that we are still in a pandemic, my thoughts were, do we all want to continually read about COVID-19? Our industry must of course stay up to date as best it can, not that it is in any way possible to read everything currently available on the topic.

Where it all started

The World Health Organization (WHO) was first informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan City, Hubei Province, China on 31 December 2019. This novel human coronavirus disease COVID-19 has now become the fifth documented pandemic since the 1918 influenza pandemic.

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025